Jim Cramer Recommended Selling These 5 Stocks

4. Catalent Inc (NYSE:CTLT)

Number of Hedge Fund Investors: 37

Healthcare company Catalent Inc (NYSE:CTLT) ranks 4th in our list of the stocks Jim Cramer was recommending to sell last year. In November 2023, Cramer recommended investors to “stay away” from the stock. Over the past six months, Catalent Inc (NYSE:CTLT) shares have lost about 4% in value.

As of the end of the third quarter of 2023, 37 hedge funds out of the 910 funds tracked by Insider Monkey had stakes in Catalent Inc (NYSE:CTLT). The most significant stakeholder of the firm during this period was Eric Bannasch’s Cadian Capital which owns a $242 million stake in Catalent Inc (NYSE:CTLT).